Member access

4-Traders Homepage  >  Shares  >  Nyse MKT  >  IGI LABORIGI       

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
IGI Laboratories, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's... 
Sector
Pharmaceuticals
Calendar
03/02Earnings Release
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating : -
More Ratings
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 31,9 M
EBIT 2014 2,80 M
Net income 2014 2,58 M
Debt 2014 -
Yield 2014 -
Sales 2015 60,4 M
EBIT 2015 15,3 M
Net income 2015 14,1 M
Debt 2015 -
Yield 2015 -
PER 2014 220,40
PER 2015 41,98
Capi. / Sales 2014 18,2x
Capi. / Sales 2015 9,63x
Capitalization 582 M
More Financials
Latest news on IGI LABORIGI
02/06 IGI LABORATORIES : To Hold Conference Call For 4th Quarter 2014 Results
01/26 Questions raised over Swiss franc retail trades
01/08 IGI LABORATORIES : To Present At 33rd Annual J.P. Morgan Healthcare Conference O..
2014 IGI LABORATORIES : Announces Three Additional ANDA Submissions
2014 IGI LABORATORIES : Announces Closing of Initial Purchasers' Exercise in Full of ..
2014 IGI LABORATORIES : Consumer Staples Industry Equities under the Scanner -- Proct..
2014 IGI LABORATORIES : Announces Closing of $125 Million of 3.75% Convertible Senior..
2014 IGI LABORATORIES : Announces Pricing of $125 Million of 3.75% Convertible Senior..
More news
Sector news Pharmaceuticals - NEC
09:14p JOHNSON & JOHNSON : Potential multimillion dollar mesh trial goes to jury
07:40p JOHNSON & JOHNSON : could bring 700 jobs to Tampa area
07:06p GILEAD SCIENCES : Announces Phase 3 Results for Investigational Once-Daily Singl..
Plus d'actualités du secteur Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF